Christopher Mutz, HEAD OF RARE DISEASE at ANI PHARMACEUTICALS INC (ANIP), sold 417 shares at $74.00 ($31K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Scheduled sale ($31k) by HEAD OF RARE DISEASE under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANIP | SELL | 2026-02-23 | $415K | — | Filing → |
| ANIP | SELL | 2026-02-17 | $538K | — | Filing → |
| ANIP | SELL | 2025-05-15 | $242K | — | Filing → |